Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
British Medical Bulletin
|
April 12, 2017
Expect the unexpected: screening for secondary findings in clinical genomics research
Michael P Mackley, Benjamin Capps
The Hastings Center Report
|
December 21, 2024
Rectifying or Reinforcing? The (In)Equity Implications of Recontacting Practices in Genomic Medicine
Michael P Mackley, Hanna Faghfoury, Lauren Chad
Journal of the Endocrine Society
|
March 3, 2022
A Rare Hemoglobin Variant (β51Pro → His) Causing Misleading Measurements of Hemoglobin A<sub>1c</sub>
Michael P Mackley, Ari Morgenthau, Manal Elnenaei, et al.
Genes
|
October 27, 2022
Rare Disease Education Outside of the Classroom and Clinic: Evaluation of the RARE Compassion Program for Undergraduate Medical Students
Ari Morgenthau, Colton Margus, Michael P Mackley, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 2, 2016
Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies
Michael P Mackley, Benjamin Fletcher, Michael Parker, et al.
Systematic Parasitology
|
October 29, 2013
Gyrodactylus laevisoides n. sp. (Monogenea: Gyrodactylidae) infecting northern redbelly dace Phoxinus eos Cope (Cyprinidae) from Nova Scotia, Canada
Stanley D King, David K Cone, Michael P Mackley, et al.
European Journal of Human Genetics : EJHG
|
February 15, 2018
Views of rare disease participants in a UK whole-genome sequencing study towards secondary findings: a qualitative study
Michael P Mackley, Edward Blair, Michael Parker, et al.
JCO Precision Oncology
|
January 7, 2022
Revisiting Risk and Benefit in Early Oncology Trials in the Era of Precision Medicine: A Systematic Review and Meta-Analysis of Phase I Trials of Targeted Single-Agent Anticancer Therapies
Michael P Mackley, Nicholas R Fernandez, Benjamin Fletcher, et al.
Clinical Genetics
|
February 14, 2026
Expanding Phenotype of GINS1 Deficiency: A Case Report and Review of the Literature
Michael P Mackley, Rae Brager, Hannah Geddie, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 21, 2017
"Not pathogenic until proven otherwise": perspectives of UK clinical genomics professionals toward secondary findings in context of a Genomic Medicine Multidisciplinary Team and the 100,000 Genomes Project
Elizabeth Ormondroyd, Michael P Mackley, Edward Blair, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
British Medical Bulletin
|
April 12, 2017
Expect the unexpected: screening for secondary findings in clinical genomics research
Michael P Mackley, Benjamin Capps
The Hastings Center Report
|
December 21, 2024
Rectifying or Reinforcing? The (In)Equity Implications of Recontacting Practices in Genomic Medicine
Michael P Mackley, Hanna Faghfoury, Lauren Chad
Journal of the Endocrine Society
|
March 3, 2022
A Rare Hemoglobin Variant (β51Pro → His) Causing Misleading Measurements of Hemoglobin A<sub>1c</sub>
Michael P Mackley, Ari Morgenthau, Manal Elnenaei, et al.
Genes
|
October 27, 2022
Rare Disease Education Outside of the Classroom and Clinic: Evaluation of the RARE Compassion Program for Undergraduate Medical Students
Ari Morgenthau, Colton Margus, Michael P Mackley, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 2, 2016
Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies
Michael P Mackley, Benjamin Fletcher, Michael Parker, et al.
Systematic Parasitology
|
October 29, 2013
Gyrodactylus laevisoides n. sp. (Monogenea: Gyrodactylidae) infecting northern redbelly dace Phoxinus eos Cope (Cyprinidae) from Nova Scotia, Canada
Stanley D King, David K Cone, Michael P Mackley, et al.
European Journal of Human Genetics : EJHG
|
February 15, 2018
Views of rare disease participants in a UK whole-genome sequencing study towards secondary findings: a qualitative study
Michael P Mackley, Edward Blair, Michael Parker, et al.
JCO Precision Oncology
|
January 7, 2022
Revisiting Risk and Benefit in Early Oncology Trials in the Era of Precision Medicine: A Systematic Review and Meta-Analysis of Phase I Trials of Targeted Single-Agent Anticancer Therapies
Michael P Mackley, Nicholas R Fernandez, Benjamin Fletcher, et al.
Clinical Genetics
|
February 14, 2026
Expanding Phenotype of GINS1 Deficiency: A Case Report and Review of the Literature
Michael P Mackley, Rae Brager, Hannah Geddie, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 21, 2017
"Not pathogenic until proven otherwise": perspectives of UK clinical genomics professionals toward secondary findings in context of a Genomic Medicine Multidisciplinary Team and the 100,000 Genomes Project
Elizabeth Ormondroyd, Michael P Mackley, Edward Blair, et al.
Page
of 3